Clinical Research Directory
Browse clinical research sites, groups, and studies.
Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
Sponsor: Novartis Pharmaceuticals
Summary
This is a prospective observational study that will enroll patients with high-risk Polycythemia Vera (PV) with at least one Thromboembolic Event (TE) after diagnosis or up to 2 years prior to diagnosis. This is a non-randomized study, and to ensure a sufficient number of patients in both cohorts, enrollment in each cohort will be terminated once the target of 150 patients has been reached.
Official title: Prospective Observational Study to Identify and Describe Predictive Factors for Thromboembolic Events in Patients With High-risk Polycythemia Vera
Key Details
Gender
All
Age Range
18 Years - 99 Years
Study Type
OBSERVATIONAL
Enrollment
242
Start Date
2023-03-02
Completion Date
2027-08-31
Last Updated
2025-09-03
Healthy Volunteers
No
Conditions
Interventions
Hydroxyurea
Prospective observational study. There is no treatment allocation. Patients prescribed with Hydroxyurea are eligible to enroll into this study.
Ruxolitinib
Prospective observational study. There is no treatment allocation. Patients prescribed with Ruxolitinib are eligible to enroll into this study.
Locations (35)
Novartis Investigative Site
Alessandria, AL, Italy
Novartis Investigative Site
Ancona, AN, Italy
Novartis Investigative Site
Bari, BA, Italy
Novartis Investigative Site
Bologna, BO, Italy
Novartis Investigative Site
Como, CO, Italy
Novartis Investigative Site
Cosenza, CS, Italy
Novartis Investigative Site
Catania, CT, Italy
Novartis Investigative Site
Florence, FI, Italy
Novartis Investigative Site
Genova, GE, Italy
Novartis Investigative Site
Lecce, LE, Italy
Novartis Investigative Site
Tricase, LE, Italy
Novartis Investigative Site
Monza, MB, Italy
Novartis Investigative Site
Milan, MI, Italy
Novartis Investigative Site
Palermo, PA, Italy
Novartis Investigative Site
Palermo, PA, Italy
Novartis Investigative Site
Piacenza, PC, Italy
Novartis Investigative Site
Padova, PD, Italy
Novartis Investigative Site
Padova, PD, Italy
Novartis Investigative Site
Pisa, PI, Italy
Novartis Investigative Site
Parma, PR, Italy
Novartis Investigative Site
Reggio Calabria, RC, Italy
Novartis Investigative Site
Reggio Emilia, RE, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Roma, RM, Italy
Novartis Investigative Site
Pagani, SA, Italy
Novartis Investigative Site
Orbassano, TO, Italy
Novartis Investigative Site
Torino, TO, Italy
Novartis Investigative Site
Terni, TR, Italy
Novartis Investigative Site
Varese, VA, Italy
Novartis Investigative Site
Vicenza, VI, Italy
Novartis Investigative Site
Verona, VR, Italy
Novartis Investigative Site
Viterbo, VT, Italy
Novartis Investigative Site
Naples, Italy
Novartis Investigative Site
Naples, Italy